Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

AccuTOXTM

Defence Therapeutics completes AccuTOXTM preclinical efficacy studies

Defence Therapeutics has successfully completed all essential preclinical efficacy studies for the company’s AccuTOXTM programme. AccuTOXTM is one of Defence’s most advanced research and development...
Vaccine enhancer technology

Defence Therapeutics granted US patent for vaccine enhancer technology

Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
biosimilars

How the potential of biosimilar medications can be unlocked

Health Europa details everything you need to know about biosimilar medications, their benefits, safety, success stories, and how biosimilars can revolutionise healthcare. The potential of...
mRNA cancer vaccine

Defence Therapeutics’ mRNA cancer vaccine testing begins

Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started. The performance of Defence’s AccumTM mRNA cancer...
mRNA cancer vaccine

Defence Therapeutics successfully develops ACCUMTM -mRNA cancer vaccine

Canadian biopharmaceutical pioneer Defence Therapeutics has revealed it has successfully conjugated mRNA molecules to AccumTM – a significant breakthrough that looks to enhance the...
biopharmaceuticals

Biopharmaceuticals – the complete guide to the future of medicine

Health Europa provides a comprehensive analysis of biopharmaceuticals to evaluate their significant potential to treat a range of diseases and their cost and value...
A new weight-loss drug will soon be available on the NHS

A new weight-loss drug will soon be available on the NHS 

A new weight-loss drug will be available to thousands of patients on the NHS as part of a specialist weight management service.  According to clinical...
A new rapid treatment for IIH headaches is in development

A new rapid treatment for IIH headaches is in development

A new injectable peptide-based drug, normally used to treat type-2 diabetes, could treat IIH headaches.   A trial conducted by the University of Birmingham has found...
New bone cancer treatment could save children’s lives

New bone cancer treatment could save children’s lives

Researchers at the University of East Anglia and The University of Sheffield have developed a new bone cancer treatment for children. Currently, bone cancer treatment...
Pregnant women facing prescription medication inequalities

Pregnant women facing prescription medication inequalities

A new study finds unwillingness to prescribe recommended medications is putting the health and lives of pregnant women at risk. New research involving investigators at the...
Researchers have developed a revolutionary new bone cancer treatment

Researchers have developed a revolutionary new bone cancer treatment 

Researchers from the University of East Anglia (UEA) have developed a new, non-invasive bone cancer treatment that is effective against all primary forms of...
Clinical trial finds temperature-stable TB vaccine safe and effective

Clinical trial finds temperature-stable TB vaccine safe and effective

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it was safe. A phase 1 trial, supported by the...
Vitamin B5 could be the key to improving myelodysplastic syndrome care

Vitamin B5 could be the key to improving myelodysplastic syndrome care

Vitamin B5 could improve the production of red blood cells in myelodysplastic syndrome patients, according to new research from Queen Mary University of London. Researchers...
NHS opioid prescriptions cut by 450,000 in four years

NHS opioid prescriptions cut by 450,000 in four years

GPs and pharmacists have cut opioid prescriptions in England by 450,000 in under four years, according to new data. Legal opioid treatments are usually only...
A new targeted treatment for acute myeloid leukaemia has been approved

A new targeted treatment for acute myeloid leukaemia has been approved

A new targeted drug for treating acute myeloid leukaemia has been granted authorisation following a study from the University of Helsinki. The aim of targeted...
B Medical Systems’ cold chain transport box receives CERTICOL label

B Medical Systems’ cold chain transport box receives CERTICOL label

The CERTICOLD quality label guarantees B Medical Systems’ cold chain transport boxes RCW25 are conforming to European GDP guidelines. B Medical Systems, a global leader...
How psychostimulants can damage dopamine production

How psychostimulants can damage dopamine production 

Researchers from MedUni Vienna have identified the mechanisms behind the unwanted effects of psychostimulants, which are used to treat neuropsychiatric disorders.  Psychostimulants interact with dopamine...
New hope for lacunar stroke treatment

New hope for lacunar stroke treatment

Two cheap and common drugs could be repurposed as a new treatment for lacunar stroke, a specific type of stroke linked to nearly half...
Almost one billion electronic prescriptions dispensed in England

Almost one billion electronic prescriptions dispensed in England

The Electronic Prescription Service has become the default method for prescribing and dispensing prescriptions in primary care in England, with almost one billion prescriptions...
Researchers suggest changes to haemophilia treatment

Researchers suggest changes to haemophilia treatment

Findings from two University Hospital Bonn studies could lead to significant changes in haemophilia treatment. Haemophilia A, which almost exclusively affects males, is the most...

Featured Special Reports

Pin It on Pinterest